As an executive, I co-founded multiple successful startups for 10+ years in areas of Information Technology and its applications for drug discovery and pharmacoinformatics.
Culturally perspicacious manager who combines a distinctive blend of analytical and strategic capacity to expedite operational and technical planning; I managed public and investor-funded projects with funds in excess of €1 Mil and was acknowledged for a solid attention on delivery, practicality, commercial mindfulness and exceptional stakeholder management skills.
Played an integral role in corporate and team formation offering best practice execution, conducive to organizational development. Recognized for expertise in Pharmaceutical and Informatics Research and Development with an extensive scientific and technical training and several honors from prominent global bodies.
2015 – Present
2011 – 2015
Chief Commercial Officer (2011-2012) Managing Director (2013-2015)
2010 – 2013
FP7 Marie-Curie fellow researcher
Institute of Bioinformatics and Systems Biology (IBIS) (2010-2011)
Institute of Structural Biology (STB) (2012-2013)
German University in Cairo (GUC)
2006 – 2010
Teaching & Research Assistant
Physical & Organic Chemistry, Computer aided Drug Design
Solutions Consulting Group, Cairo
Market researcher, Business consultant
Award winning Innovative multi-compartment capsule solution. Its modular design offers flexibility while its high potential comes from its simplicity; just an extra cap is filled and added to the lower end of a conventional hard or soft gelatin capsule.
Web-based platform to automate and simplify the QSAR modeling process. It uses advanced machine learning algorithms and a large number of donated descriptor packages from industry and academia. Developed by Helmholtz Zentrum München and eADMET GmbH.
Full stack software development company. Established in 2006, Interdesigns continues to serve clients ranging from small SME to the Fortune 500.
develops and markets innovative IT solutions for the prediction of important properties of chemicals and drugs, especially physical and PK/PD characteristics.
Including data scrapping, correcting data problems, data storage, modeling and interpretation. Machine Learning and Data Mining for business analytics, high-level modeling and simulation, forecasting and Data visualization.
Perform PK/PD study design, analysis, interpretation and reporting across preclinical and clinical studies (Phases 1 and 2) stages of drug development, from simple non-compartmental analyses (NCA) to customized models and simulations.
In silico modeling for drug discovery and vHTS screening, physicochemical and ADME/Tox property estimation using linear and non-linear QSPR/QSAR, model interpretation using MMPs and applicability domain assessment.
Interim assignments for technology based projects (especially startups). Main focus in healthcare and Information technology. Coordination and planning of in house R&D activities as well as Technology transfer and licensing.
“The sciences do not try to explain, they hardly even try to interpret, they mainly make models. ”
Goethestr. 2, 85354, Freising, Germany
© 2015 Ahmed Mohamed Abdelaziz. All rights reserved. By : Interdesigns®
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.